CARLSBAD, Calif., May 5, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2021 virtual Annual Meeting of Stockholders followed by a general corporate update on Wednesday, June 2, 2021. This event will be webcast live on the internet in place of an in-person meeting.
The agenda for the event is as follows:
Further information, including links and materials, are available on our website at https://ir.ionispharma.com/events-and-presentations/upcoming-events.
About Ionis PharmaceuticalsFor more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.
###
View original content to download multimedia:http://www.prnewswire.com/news-releases/ionis-to-host-2021-virtual-annual-meeting-of-stockholders-301283892.html
SOURCE Ionis Pharmaceuticals, Inc.